Article Information
History
- May 27, 2020.
Article Versions
- Version 1 (May 8, 2020 - 02:24).
- Version 2 (May 12, 2020 - 12:48).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- E Tuaillon1,*,
- K Bolloré2,
- A Pisoni1,
- S Debiesse2,
- C Renault2,
- S Marie3,
- S Groc3,
- C Niels3,
- N Pansu3,
- AM Dupuy3,
- D Morquin3,
- V Foulongne1,
- A Bourdin3,
- V Le Moing3 and
- P Van de Perre1
- 1Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France
- 2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France
- 3Montpellier University Hospital, Montpellier, France
- ↵*Corresponding author: e-tuaillon{at}chu-montpellier.fr
Posted May 27, 2020.
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
